OR WAIT null SECS
April 15, 2023
Unique solutions are required to protect inherently unstable messenger RNA.
This article reviews a range of techniques available for separative analysis of mRNA therapeutics, their associated impurities, and delivery vehicles.
Considerable efforts have been made over the years to resolve the key issues of stability and delivery of RNA-based therapeutics.
The complexity of the RNA production process creates challenges.
April 06, 2023
Nicole Lewis, PVP Program Manager at Boston Children's Hospital, discusses the science behind precision vaccines, a form of personalized vaccines.
April 03, 2023
Despite the advantages intensified processes can offer developers, there are still some obstacles to overcome before broader application of new technologies will be implemented.
April 02, 2023
Alternative approaches to freeze-drying are gaining popularity and will help to overcome some of the challenges associated with conventional lyophilization.
Considering the differences between small- and large-molecule drug products can help determine analytical testing methods for E&L.
March 30, 2023
Takeda received approval in Japan for a subcutaneous injection formulation of Entyvio (vedolizumab) for treating ulcerative colitis.
March 17, 2023
Polyplus’ LipidBrick is designed to expand the scope of lipid nanoparticle formulation usage in mRNA therapeutics and vaccine development.
